# Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion

Study · id `cardio:ct-nct03121430` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03121430](<https://clinicaltrials.gov/study/NCT03121430>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03121430

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 138 participants.

## Technical summary

Registry record NCT03121430. Randomized; single masking; primary purpose treatment. Start 2018-10-22 (actual); primary completion 2020-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 138 participants (planned count; ClinicalTrials.gov record NCT03121430, source copy `cardio:ctgov-nct03121430-2019-02-18`, retrieved 2026-10-31)
- Started: 2018-10-22 (actual) (ClinicalTrials.gov record NCT03121430, source copy `cardio:ctgov-nct03121430-2019-02-18`, retrieved 2026-10-31)
- Primary completion: 2020-07 (anticipated) (ClinicalTrials.gov record NCT03121430, source copy `cardio:ctgov-nct03121430-2019-02-18`, retrieved 2026-10-31)
- Completion: 2021-02 (anticipated) (ClinicalTrials.gov record NCT03121430, source copy `cardio:ctgov-nct03121430-2019-02-18`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT03121430, source copy `cardio:ctgov-nct03121430-2019-02-18`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03121430-2019-02-18`, retrieved 2026-10-31)

## The registry's words

- Brief title: Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion
- Condition: Peripheral Arterial Disease
- Condition: Superficial Femoral Artery Stenosis
- Condition: Superficial Femoral Artery Occlusion
- Intervention (Device): Drug eluting peripheral vascular stent system
- Intervention (Device): Nitinol Stent System
- Lead sponsor: Zhejiang Zylox Medical Device Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Guangzhou Osmunda Medical Device Technology, Inc., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Zhejiang Zylox Medical Device Co., Ltd. (`cardio:org-zhejiang-zylox-medical-device-co-ltd`)

## Provenance

Content hash: de94115065f2904eb1aa87295f42ce7894dac752c210918d75cace396b429ace
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
